About
Medeia develops biomedical software and hardware to monitor physiological activity. Their products include systems for heart rate variability, autonomic nervous system testing, EEG, and mobile cardiac telemetry. These tools support clinical, research, and educational uses by providing precise measurements of cardiovascular and neurological functions.
The VitalScan ANS system offers automated autonomic function testing for fields like neurology and cardiology. CardioView delivers real-time outpatient ECG monitoring with vital signs tracking. BrainView analyzes brain electrical activity for cognitive assessment, including memory and attention, using non-invasive EEG and related technologies.
Medeia focuses on reliable, integrated solutions for healthcare providers and researchers. Established in 1992, the company tailors products to uncover hidden health issues and inform patient management. Their approach emphasizes measured monitoring to optimize outcomes in acute care settings.
Longevity Contribution
- Comprehensive integration of HRV, ANS, PWV, EEG, and ECG in single platforms like VitalScan and BrainView.
- Wireless and portable designs, such as CardioView for real-time outpatient monitoring and SleepStudy PSG.
- Automated analysis with cloud-based reports for quick clinical decision-making.
- Support for both research and clinical applications across neurology, cardiology, and cognitive health.